SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
BSE: 524372|NSE: ORCHIDCHEM|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 30, 17:00
59.65
3.85 (6.9%)
VOLUME 730,148
LIVE
NSE
Jun 30, 17:00
59.70
3.95 (7.09%)
VOLUME 2,066,632
Announcements on Orchid Chemical

17th-Jun-2015 16:40Source: BSE

Orchid Chemical- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

17th-Jun-2015 15:49Source: BSE

Orchid Chemical- Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg...

17th-Jun-2015 15:38Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that Orchid has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets...

12th-Jun-2015 18:20Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has received approval from the USFDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in ...

12th-Jun-2015 18:12Source: BSE

Orchid Chemical- Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in 1.5 mg, 3 mg...

10th-Jun-2015 17:29Source: BSE

Orchid Chemical- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

1st-Jun-2015 18:38Source: BSE

Orchid Chemical- Change in Directorate

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that Shri Sundaram Yuvaraj has vacated his office pursuant to Section 167(b) of the Companies Act 2013 from the Board of Orchid and Shri R. Kann...

29th-May-2015 10:12Source: BSE

Orchid Chemical- Financial Results & Results Press Release for March 31, 2015 (Audited)

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of Results Press Release for the period ended March 31, 2015.

29th-May-2015 09:25Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.

29th-May-2015 09:10Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 28, 2015 titled "Orchid Pharma registers turnover of Rs. 1753 crore in FY15".

1 2 3 4 5 Next >>
Quick Links for Orchid Chemicals and Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.